Company intelligence / Profile preview

WellSkin

Mississauga, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

WellSkin Inc. was a Canadian specialty pharmaceutical company focused on the development and commercialization of dermatological products. Founded in 1994 and headquartered in Mississauga, Ontario, the company became well-known for its clinically-proven skincare brands, including Glaxal Base and Barriere. WellSkin's portfolio addressed various skin conditions such as dry skin, eczema, and psoriasis, emphasizing skin barrier repair and hydration. In 2010, the company was acquired by Galderma, the world's largest independent dermatology company, which integrated WellSkin's products into its global portfolio to strengthen its presence in the Canadian and international skincare markets.

Therapeutic areas: Dermatology
Modalities: Small moleculePeptides
Industry: Biotech

Beyond the preview

Go deeper on WellSkin.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on WellSkin.

Explore the full profile